Thermo Fisher acquires gene therapy CDMO Brammer Bio
Thermo Fisher Scientific bolsters its gene therapy capabilities by acquiring Brammer Bio for $1.7bn, as the market becomes an ‘increasing focus’ for customers.
Archives for March 25, 2019
Merck KGaA invests €1bn in Darmstadt HQ
The German company intends to spend €1bn to expand its company headquarters, invest in manufacturing capabilities and further train staff members.
IBM Watson partnership to remove ‘drudgery’ of clinical trial enrollment
The four-hospital health system, Health Quest, will use IBM Watson for Clinical Trial Matching to match patients to clinical trials throughout its hospital.
Parexel Biotech conducting Ph IIa neurodegenerative disease trial
AlzProtect is collaborating with Parexel Biotech to advance a Phase IIa clinical trial of its lead candidate, AZP2006, which is being developed for the treatment of a rare neurodegenerative disease.
Trianni mouse model tapped for HIV vaccine research
Trianni and San Diego Biomedical Research Institute enter license agreement for the use of the Trianni Mouse in HIV vaccine research.
$40m financing to expand AI-powered platform for clinical trials: Saama
The clinical data analytics platform firm has raised $75m since 2015 and will continue to enhance both the platform and applications with new capabilities, says CEO.
Repackaged sartan tablets also face recalls
Sartan recalls continue as Legacy Pharmaceutical Packaging recalls 40 lots of losartan tablets at the consumer level.
FDA approves first drug specifically for postpartum depression
The treatment, developed by Sage Therapeutics, is administered via continuous IV infusion for 60 hours.